<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>StockStream - NVO News</title>
<link>https://stockstream.it.com/stocks/NVO</link>
<description>Latest news and analysis for NVO stock on StockStream.</description>
<language>en-us</language>
<lastBuildDate>Wed, 22 Jul 2026 21:31:11 +0000</lastBuildDate>
<atom:link href="https://stockstream.it.com/stocks/NVO/feed.xml" rel="self" type="application/rss+xml"/>
<ttl>15</ttl>
<item><title>Agios Pharmaceuticals’ Phase 2 Failure Rocks Novo Nordisk's Market Position</title><link>https://stockstream.it.com/news/nvo-agios-phase-2-failure-impact</link><description>Agios Pharmaceuticals' Phase 2 failure impacts NVO's market dynamics. Investors are watching closely for potential fallout. Here's what Wall Street is watching.</description><pubDate>Wed, 22 Jul 2026 00:15:05 +0000</pubDate><guid isPermaLink="true">https://stockstream.it.com/news/nvo-agios-phase-2-failure-impact</guid><category>Healthcare</category></item>
</channel>
</rss>